HCC Risk Stratification and Precision Screening

Although patients with cirrhosis are at high risk of HCC, there is variation in risk among individuals. We are collaborating with Dr. Hoshida at UT Southwestern to validate a novel blood-based signatures to help identify patients at highest risk for HCC development. The biomarker has shown promising results in several cohort studies, and we continue to evaluate its ability to enable tailored (precision) screening strategies.